Teuscher A U
Medizinischen Universitätspoliklinik, Inselspital Bern, Schweiz.
Wien Med Wochenschr. 1996;146(16):439-42.
The term "diuretics" describes a concerning pharmacological action and side effects heterogeneous class of drugs. The special advantage of using diuretics includes reducing edema and expanded plasma volume often associated with hypertension and cardiovascular disease. Diuretics are one of the 5 major classes of antihypertensive agents recommended for the initial drug therapy of hypertension. However, currently treatment of hypertension with diuretics is controversial, because of potentially adverse effects on the cardiovascular risk profile, including deterioration in glucose control especially in patients with impaired glucose tolerance. Additionally there is concern about excess mortality associated with diuretic therapy and diabetes mellitus. The metabolic side effects on glucose metabolism and lipid profile are related to the type of diuretic and its dosage. The adverse effects of thiazides on insulin action, glycemia and lipid profile are dose dependent and can be minimized by using low doses. In contrast, indapamide seems not to alter glucose metabolism and lipid profile. The choice of diuretic depends on concomitant disease. In patients with nephropathy potassium sparing agents should not be used, however furosemid can be used even in high doses. Beside focus on indication of diuretics in patients with diabetes and their metabolic side effects treatment of therapy resistant hypertension in these patients are discussed in this review.
“利尿剂”一词描述了一类具有令人关注的药理作用和副作用的异质性药物。使用利尿剂的特殊优势包括减轻水肿以及减少通常与高血压和心血管疾病相关的血浆容量增加。利尿剂是推荐用于高血压初始药物治疗的5大类抗高血压药物之一。然而,目前使用利尿剂治疗高血压存在争议,因为其可能对心血管风险状况产生不良影响,包括血糖控制恶化,尤其是在糖耐量受损的患者中。此外,人们还担心利尿剂治疗与糖尿病相关的额外死亡率。对葡萄糖代谢和血脂状况的代谢副作用与利尿剂的类型及其剂量有关。噻嗪类药物对胰岛素作用、血糖和血脂状况的不良影响是剂量依赖性的,通过使用低剂量可以将其降至最低。相比之下,吲达帕胺似乎不会改变葡萄糖代谢和血脂状况。利尿剂的选择取决于伴随疾病。在肾病患者中不应使用保钾利尿剂,然而即使大剂量使用呋塞米也是可以的。除了关注利尿剂在糖尿病患者中的适应证及其代谢副作用外,本文还讨论了这些患者中难治性高血压的治疗。